| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.29 | 0.007 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.15 | 0.009 |